Tert-Butylamine

Tert-Butylamine

SCHEMBL9107540

CC(C)(C)N.CCCC(c1ccccc1)c1ccc(O)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.45
CNR2 P34972 2/20 0.45
ESR1 P03372 4/20 0.45
ESR2 Q92731 3/20 0.45
AOC3 Q16853 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
IDO1 P14902 1/20 0.43
TDO2 P48775 1/20 0.43
HRH1 P35367 4/20 0.42
LMNA P02545 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP3A4 P08684 2/20 0.41
CYP1A2 P05177 1/20 0.41
PGR P06401 1/20 0.41
CHRM2 P08172 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
AR P10275 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1973610 0.91 ESR1 (0.52) CNR1CNR2ESR1ESR2AOC3
SCHEMBL69257 0.85 ESR1 (0.57) CNR1CNR2ESR1ESR2MEN1
Butylamine SCHEMBL9108656 0.83 HRH1 (0.55) CNR1CNR2ESR1ESR2AOC3
Ammonia Solution, Strong SCHEMBL6327541 0.83 ESR1 (0.55) CNR1CNR2ESR1ESR2MEN1
SCHEMBL3117867 0.83 CNR1 (0.45) CNR1CNR2ESR1ESR2AOC3
Benzylamine SCHEMBL9392739 0.81 ABAT (0.48) CNR1CNR2ESR1ESR2MEN1
Hydrogen Peroxide SCHEMBL27864054 0.81 HRH1 (0.54) CNR1CNR2AOC3MEN1KMT2A
SCHEMBL7517085 0.80 SIGMAR1 (0.50) CNR1CNR2ESR1ESR2MEN1
Benzylamine SCHEMBL9396063 0.80 ABAT (0.47) CNR1CNR2ESR1ESR2MEN1
SCHEMBL4946739 0.80 ESR1 (0.54) CNR1CNR2ESR1ESR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995010269-A1 TREATMENT OF URINARY INCONTINENCE AND OTHER DISORDERS WITH R-TERODILINE AND HYDROXYLATED DERIVATIVES THEREOF SEPRACOR, INC. (US) 1995-04-20 WO claimed
WO-1995010270-A1 METHOD FOR TREATING URINARY INCONTINENCE USING OPTICALLY PURE S-TERODILINE SEPRACOR, INC. (US) 1995-04-20 WO claimed